MYLI
MRNA icon

Meiji Yasuda Life Insurance’s Moderna MRNA Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,871
Closed -$441K – 280
2023
Q1 		$441K Buy
+2,871
New +$474K 0.01% 229
2022
Q4 		– Sell
-3,191
Closed -$377K – 289
2022
Q3 		$377K Buy
+3,191
New +$484K 0.01% 244
2021
Q4 		– Sell
-880
Closed -$339K – 320
2021
Q3 		$339K Buy
+880
New +$325K 0.01% 266

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Meiji Yasuda Life Insurance's MRNA Position: Q2 2023 in Review

Meiji Yasuda Life Insurance sold out of Moderna (MRNA) in Q2 2023, closing a stake of 2,871 shares — an estimated $441K sold.

Meiji Yasuda Life Insurance first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $441K in Q1 2023. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Meiji Yasuda Life Insurance reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Meiji Yasuda Life Insurance sold 2,871 Moderna shares in Q2 2023, an estimated $441K.
  • Meiji Yasuda Life Insurance first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Meiji Yasuda Life Insurance's Moderna position peaked at $441K in Q1 2023.
  • 966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Meiji Yasuda Life Insurance's 13F filing for Q2 2023, filed 14 Aug 2023.